-

Fasano Longevity Conference to Cover Investments, Mortality Research and Life Settlements

WASHINGTON--(BUSINESS WIRE)--The Fasano Longevity Conference, which will be held on November 1st, will include a wide range of topics bearing on longevity markets, mortality and the economy.

The Conference will start this year with an analysis of the Post-Covid Investment Outlook by keynote speaker, Tony Roth - Chief Investment Officer of Wilmington Trust. Tony will be followed by two research presentations: The Risks and Benefits of Marijuana versus Opioids in Pain Relief by Dr. Steven Rigatti and The Impact of Sex on Gene Expression, Disease and Mortality by Dr. Barbara Stranger of Northwestern University.

The morning sessions will end with a “State of the Life Settlement Market” presentation by LISA Executive Director, Bryan Nicholson, while the afternoon sessions will begin with a legal analysis of current STOLI litigation affecting the life settlement industry by James Westerlind of Arent Fox and Kenneth Brown of Williams & Connolly.

The final three sessions will cover different aspects of mortality: Matt Morton, Chief Actuary of LTCG, will draw on an extensive database of long-term care patients and share his insight on the changes in mortality that occur as functional status declines, while PBI CEO, John Bikus, will detail how artificial intelligence and obituary research has filled the death identification gap created by regulatory changes limiting the efficacy of the Master Death File.

The Conference will close with an analysis by Dan Zollars of Maple Life Analytics of Mortality Differences in Secondary versus Tertiary Life Settlement Markets.

Said Michael Fasano, President of Fasano Associates, "This year's Conference covers a very interesting mix of investment, life settlement industry and research issues.” Fasano described his Conference as "Investor Focused."

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets and has been favored by the investment and financial community. This year’s Conference will be live in Washington, DC, although a virtual option will be offered to those not yet ready to travel: https://fasanoassociates.com/annual-conference-2021/

Discounts from the $495 Conference fee will be available to LISA, ELSA, ILMA and BVZL trade association members.

About Fasano Associates:

Fasano Associates is a leading underwriting consulting firm serving the life, health, annuity and life settlement industries.

Fasano Associates


Release Summary
The Fasano 2021 Conference will be the best ever!
Release Versions

More News From Fasano Associates

200 Attend Fasano Longevity Conference Focused on Longevity, Medical Research and Politics

WASHINGTON--(BUSINESS WIRE)--200 Attend Fasano Longevity Conference Focused on Longevity, Medical Research and Politics...

Fasano Longevity Conference to Cover Politics, Medical Research and Investments

WASHINGTON, D.C.--(BUSINESS WIRE)--The Fasano Longevity Conference, which will be held on November 7th, will include a wide range of topics bearing on longevity markets. The Conference will start this year with an analysis of the Mid-Term Election Outlook by keynote speaker, Amy Walter – National Editor of the Cook Political Report. Amy will be followed by Jay Jackson, CEO of Abacus Life Settlements, who will share his insights on the State of the Life Settlement Market and what is needed to br...

200 Attend Fasano Longevity Conference Focused on Investments, Mortality Research and Life Settlements

WASHINGTON--(BUSINESS WIRE)--200 longevity professionals attended the November 1st Fasano Longevity Conference in Washington, DC. The Conference, which was in hybrid format, with about half attending in person and half attending virtually, focused on a wide range of topics bearing on longevity markets, mortality and the economy. The Conference opened with two research presentations: The Impact of Sex on Gene Expression, Disease and Mortality by Dr. Barbara Stranger of Northwestern University an...
Back to Newsroom